LINC02092

Across TCGA pan-cancer cohorts, LINC02092 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02092 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02092 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02092 expression acts as an unfavorable survival marker, although some lineages such as READ and UCS show a favorable association.

BLCA, KIRC, and CESC are the cancer types where LINC02092 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.306	0.534	<.001	63	view →
KIRC	DFS	Tertile	All	0.506	0.666	<.001	56	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	48	view →
ESCA	DFS	Tertile	All	0.401	0.827	.011	30	view →
HNSC	DFS	Tertile	III,IV	0.334	0.540	.024	30	view →
LUAD	OS	Tertile	All	0.565	0.705	.005	30	view →
LUSC	DFS	Tertile	II,III,IV	0.529	0.731	.009	27	view →
READ	OS	Tertile	II,III,IV	1.000	0.559	.013	21	view →
SKCM	OS	Tertile	IV	0.182	0.654	.021	18	view →
UCS	OS	Tertile	IV	0.844	0.250	.016	18	view →
STAD	DFS	Tertile	All	0.415	0.657	.020	14	view →
PAAD	OS	Median	III,IV	0.629	1.000	.022	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02092–BLCA (DFS)

Open the BLCA breakdown →